Trials / Completed
CompletedNCT00165724
Alzheimer's Disease Long-term Follow-up Study (ALF Study)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Eisai Korea Inc. · Industry
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- —
Summary
Open study for efficacy and safety of donepezil treatment during 48 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Donepezil Hydrochloride |
Timeline
- Start date
- 2004-06-30
- Primary completion
- 2006-07-31
- Completion
- 2006-12-31
- First posted
- 2005-09-14
- Last updated
- 2021-12-30
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00165724. Inclusion in this directory is not an endorsement.